A bioinformatics approach reveals novel interactions of the OVOL transcription factors in the regulation of epithelial – mesenchymal cell reprogramming and cancer progression

by Roca, Hernan, Pande, Manjusha, Huo, Jeffrey S, Hernandez, James, Cavalcoli, James D, Pienta, Kenneth J, McEachin, Richard C
Published 2014

Alternative CD44 splicing identifies epithelial prostate cancer cells from the mesenchymal counterparts

by Hernandez, James R., Kim, John J., Verdone, James E., Liu, Xin, Torga, Gonzalo, Pienta, Kenneth J., Mooney, Steven M.
Published 2015

Neutralizing blood-borne polyphosphate in vivo provides safe thromboprotection

by Labberton, Linda, Kenne, Ellinor, Long, Andy T., Nickel, Katrin F., Di Gennaro, Antonio, Rigg, Rachel A., Hernandez, James S., Butler, Lynn, Maas, Coen, Stavrou, Evi X., Renné, Thomas
Published 2016

Transcription Factors OVOL1 and OVOL2 Induce the Mesenchymal to Epithelial Transition in Human Cancer

by Roca, Hernan, Hernandez, James, Weidner, Savannah, McEachin, Richard C., Fuller, David, Sud, Sudha, Schumann, Taibriana, Wilkinson, John E., Zaslavsky, Alexander, Li, Hangwen, Maher, Christopher A., Daignault-Newton, Stephanie, Healy, Patrick N., Pienta, Kenneth J.
Published 2013

Glycolysis is the primary bioenergetic pathway for cell motility and cytoskeletal remodeling in human prostate and breast cancer cells

by Shiraishi, Takumi, Verdone, James E., Huang, Jessie, Kahlert, Ulf D., Hernandez, James R., Torga, Gonzalo, Zarif, Jelani C., Epstein, Tamir, Gatenby, Robert, McCartney, Annemarie, Elisseeff, Jennifer H., Mooney, Steven M., An, Steven S., Pienta, Kenneth J.
Published 2014